{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:48:34Z","timestamp":1791157714395,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007312","name":"Cleveland Clinic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005242","name":"Heed Ophthalmic Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.ophtha.2008.12.004","type":"journal-article","created":{"date-parts":[[2009,5,4]],"date-time":"2009-05-04T04:45:36Z","timestamp":1241412336000},"page":"981-989.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Ocular and Systemic Autoimmunity after Successful Tumor-Infiltrating Lymphocyte Immunotherapy for Recurrent, Metastatic Melanoma"],"prefix":"10.1016","volume":"116","author":[{"given":"Steven","family":"Yeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neel K.","family":"Karne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sid P.","family":"Kerkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles K.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Sherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Restifo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Nussenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2008.12.004_bib1","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1245\/s10434-007-9448-y","article-title":"Stage-IV melanoma and pulmonary metastases: factors predictive of survival","volume":"14","author":"Neuman","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib2","first-page":"193","article-title":"Prognostic factors in 1,521 melanoma patients with distant metastases","volume":"181","author":"Barth","year":"1995","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ophtha.2008.12.004_bib3","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2345::AID-CNCR8>3.0.CO;2-K","article-title":"Prolonged survival of 2 years or longer for patients with disseminated melanoma: an analysis of related prognostic factors","volume":"79","author":"Brand","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ophtha.2008.12.004_bib4","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1056\/NEJMcibr045001","article-title":"Shedding light on immunotherapy for cancer","volume":"350","author":"Rosenberg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2008.12.004_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"suppl","key":"10.1016\/j.ophtha.2008.12.004_bib6","first-page":"S11","article-title":"High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update","volume":"6","author":"Atkins","year":"2000","journal-title":"Cancer J Sci Am"},{"key":"10.1016\/j.ophtha.2008.12.004_bib7","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1200\/JCO.2005.00.240","article-title":"Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma","volume":"23","author":"Dudley","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ophtha.2008.12.004_bib9","doi-asserted-by":"crossref","first-page":"6548","DOI":"10.4049\/jimmunol.177.9.6548","article-title":"Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes","volume":"177","author":"Johnson","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","article-title":"Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients","volume":"26","author":"Dudley","year":"2003","journal-title":"J Immunother"},{"key":"10.1016\/j.ophtha.2008.12.004_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ophtha.2008.12.004_bib12","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","article-title":"Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature","volume":"131","author":"Read","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib13","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1167\/iovs.05-1547","article-title":"Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens","volume":"47","author":"Sugita","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2008.12.004_bib14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/intimm\/8.5.799","article-title":"Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease","volume":"8","author":"Sugita","year":"1996","journal-title":"Int Immunol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib15","first-page":"771","article-title":"Uveitis and vitiligo associated with BCG treatment for malignant melanoma","volume":"76","author":"Donaldson","year":"1974","journal-title":"Surgery"},{"key":"10.1016\/j.ophtha.2008.12.004_bib16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00002371-200411000-00008","article-title":"Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis","volume":"27","author":"Robinson","year":"2004","journal-title":"J Immunother"},{"key":"10.1016\/j.ophtha.2008.12.004_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1245\/ASO.2005.03.536","article-title":"Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I\/II study","volume":"12","author":"Maker","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib18","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00417-003-0787-5","article-title":"Vogt-Koyanagi-Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up","volume":"241","author":"Aisenbrey","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archderm.1978.01640150075022","article-title":"Uveitis, poliosis, hypomelanosis, and alopecia in a patient with malignant melanoma","volume":"114","author":"Sober","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","article-title":"Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy","volume":"19","author":"Rosenberg","year":"1996","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.cmr.0000222590.68234.1d","article-title":"The course of melanoma-associated vitiligo: report of a case","volume":"16","author":"Daneshpazhooh","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ophtha.2008.12.004_bib22","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1038\/sj.jid.5700545","article-title":"Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma","volume":"126","author":"Boasberg","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"354","author":"Gogas","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2008.12.004_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20030590","article-title":"Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells","volume":"198","author":"Overwijk","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.ophtha.2008.12.004_bib25","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1073\/pnas.0710929105","article-title":"Effective tumor treatment targeting a melanoma\/melanocyte-associated antigen triggers severe ocular autoimmunity","volume":"105","author":"Palmer","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ophtha.2008.12.004_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1076\/ceyr.23.3.166.5461","article-title":"Effect of acetazolamide on outward permeability of blood-retina barrier using differential vitreous fluorophotometry","volume":"23","author":"Takahashi","year":"2001","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ophtha.2008.12.004_bib27","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archopht.1989.01070020519031","article-title":"Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa","volume":"107","author":"Fishman","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2008.12.004_bib28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0161-6420(96)30567-8","article-title":"A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis","volume":"103","author":"Whitcup","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2008.12.004_bib29","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ophtha.2003.08.037","article-title":"Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography","volume":"111","author":"Markomichelakis","year":"2004","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200801258X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200801258X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:57:35Z","timestamp":1758981455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164200801258X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S016164200801258X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.12.004","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular and Systemic Autoimmunity after Successful Tumor-Infiltrating Lymphocyte Immunotherapy for Recurrent, Metastatic Melanoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2008.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}